-
Oct 29, 2012, 15:00
by
Michael Croft
Oct 29 | eClin | Vendor Contributed Comment | 2012 has been a bumpy ride for pharmaceutical firms, exacerbated by a significant loss of revenue related to drug patent expirations. It’s been estimated that drugs scheduled to go off patent this year represent over $30 billion in sales. A wealth of new tools and technological advancements may be the answer for how researchers can discover new, life-saving therapies more quickly while simultaneously cutting costs. One development that is generating a lot of industry buzz is the integration of electronic data capture (EDC) platforms, traditionally used to manage clinical trials, with those used within the health care industry to create and maintain electronic health records (EHR).
Full story
-
Oct 17, 2012, 12:00
by
Michael Croft
Oct 17 | News Brief | MMG, a clinical trial patient recruitment firm, and Remedy Health Media are partnering to deliver unique access to a larger pool of qualified potential clinical trial participants.
Full story
-
Oct 16, 2012, 14:00
by
Michael Croft
Oct 16 | News Brief | BioClinica has announced the immediate availability of new and expanded imaging services critical for clinical trials in the area of osteoarthritis.
Full story
-
Oct 16, 2012, 14:00
by
Michael Croft
Oct 16 | Seeking Alpha | Do clinical trial results sway biotech investors? Investors may be able to determine FDA approvals from trials, but then again they may not.
Full story
-
Oct 15, 2012, 07:00
by
Michael Croft
Oct 8 | News Brief | Nextrials and InClin sign partnership to link Prism to CRO services.
Full story
-
Oct 15, 2012, 06:00
by
Michael Croft
Oct 15 | eCliniqua | Life science vendors must become more strategic and price-sensitive to “stay in the game” with their clients in the trillion-dollar drug development industry, says Andreas Scherer, managing partner at consulting firm Salto Partners. The industry consensus is that drug research takes too long and has grown unsustainably expensive.
Full story
-
Oct 15, 2012, 06:00
by
Michael Croft
Oct 9 | News Brief | DATATRAK International has announced that ABX-CRO, a company providing global molecular and advanced imaging services for oncology and neuroscience to the pharmaceutical and biotechnology industries, is its first imaging partner.
Full story
-
Oct 15, 2012, 06:00
by
Michael Croft
Oct 9, 2012 | News Brief | Sanofi has announced a two-year agreement with Massachusetts General Hospital (MGH) aimed at furthering translational medicine research to develop new treatments for various types of hematological malignancies and solid tumors.
Full story
-
Oct 1, 2012, 12:00
by
Michael Croft
Oct 1 | News Brief | WorldCare Clinical (WCC) has announced its new Endpoint Assessment Committee (EAC) services for blinded independent central review of clinical trial data. WCC’s EAC services include expert assessments by physicians drawn from multiple therapeutic areas for comprehensive efficacy and safety reviews.
Full story
-
Sep 24, 2012, 13:55
by
Michael Croft
Sep 24 | eCliniqua | Medidata Solutions has deployed Opscode Hosted Chef to automate its hybrid infrastructure for clinical development: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, to clinical data capture and management, safety events capture, medical coding, and business analytics.
Full story
-
Sep 24, 2012, 13:20
by
Michael Croft
Sep 24 | News Brief | Sanofi has selected BioClinica's OnPoint as the company's standard CTMS (Clinical Trial Management System). With this decision, Sanofi plans to utilize OnPoint CTMS for all clinical trial management activity.
Full story
-
Sep 24, 2012, 13:00
by
Michael Croft
Sep 24 | Cancer Grace | A week after releasing favorable Phase II results for the novel vascular-targeting immunotherapy for non-small cell lung cancer, bavituximab, study sponsor Peregrine Pharmaceuticals has announced "major discrepancies" in the trial.
Full story
-
Sep 20, 2012, 12:35
by
Michael Croft
Sep 20 | eCliniqua | A special one-day conference next month will showcase many of the leading figures in the emerging field of adaptive trial designs, with a view to helping organizations recognize their benefits and understand the keys to successful implementation.
Full story
-
Sep 17, 2012, 12:55
by
Michael Croft
Sep 17 | Product Brief | The latest version of iMedNet EDC was announced today. iMedNet EDC makes electronic data capture functionality practical for any type of research initiative, even very small studies of short duration.
Full story
-
Sep 17, 2012, 07:00
by
Michael Croft
Sep 17 | eCliniqua | Mark Mathieu—director of Strategic Research at PAREXEL Consulting—is the founding editor of the PAREXEL Biopharmaceutical R&D Statistical Sourcebook. As such, he is the ideal person to discuss the highlights and nuances that emerge in the latest edition of the sourcebook (2012-13). Mathieu recently spoke to Barnett International’s Rachel Meyers.
Full story
-
Sep 13, 2012, 15:50
by
Michael Croft
PSFK | Boehringer Ingelheim has developed a Facebook game called Syrum. The health of the world is in the user's hands, and players can collaborate with others to save it.
Full story
-
Sep 13, 2012, 07:00
by
Michael Croft
Sep 13 | eCliniqua Exclusive | EDC purist Isis Pharmaceuticals is stepping up its partnering activity with BioClinica, Inc. to include larger and more complex clinical trials within its expansive antisense drug development program. Up to 20 new trials are on the docket for next year, including several phase III studies involving thousands of participants.
Full story
-
Sep 12, 2012, 12:00
by
Michael Croft
Sep 12 | CDISC | The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) have announced the launch of the Coalition For Accelerating Standards and Therapies (CFAST), a follow-up to the partnership agreement signed earlier this year.
Full story
-
Sep 12, 2012, 11:10
by
Michael Croft
Sept 12 | PharmaTimes | Mytrus has launched an iPad app explaining the informed consent process.
Full story
-
Sep 11, 2012, 07:00
by
Michael Croft
Sep 11 | Guest Commentary | Regulators are paying increased attention to sponsors within the realm of vendor oversight. Clinical Trial Sponsors must include vendor oversight in any assessment of inspection readiness on their mid-stage development programs, and once the gaps have been identified, apply preventative actions across all outsourced programs in development.
Full story